WSTAM
ARQT icon

Wilbanks Smith & Thomas Asset Management’s Arcutis Biotherapeutics ARQT Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20,000
Closed -$64.6K – 529
2023
Q4 		$64.6K Buy
+20,000
New +$64.6K ﹤0.01% 515